Stem cells as future therapy in cardiology

Hospital Medicine

Volumn 66, Issue 4, 2005, Pages 215-220

  Lindsay, Alistair C ^a   Halcox, Julian P J ^b  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; GREEN FLUORESCENT PROTEIN; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ADOPTIVE IMMUNOTHERAPY; ANGIOPLASTY; BONE MARROW; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CARDIOLOGY; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; DRUG SAFETY; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMATOPOIETIC STEM CELL; HUMAN; LEUKOCYTE COUNT; PHENOTYPE; REVASCULARIZATION; REVIEW; SAFETY; STEM CELL; STEM CELL TRANSPLANTATION;

EID: 18244398945     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2005.66.4.18438     Document Type: Review

References (39)

1. Asahara T, Murohara T, Sullivan A et al (1997) Isolation of progenitor endothelial cells for angiogenesis. Science 275: 964-7
2. Asahara T, Masuda H, Takahashi T et al (1999) Bone marrow origin of endothelial progenitor cells responsible for post-natal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-8
3. Assmus B, Shachinger V, Teupe C et al (2002) Transplantation of progenitor and regeneration enhancement on acute myocardial infarction (TOPCARE-AMI). Circulation 106: 3009-17
4. Balsam LB, Wager AJ, Christensen JL et al (2004) Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428: 668-73
5. Dick JE (2003) Self-renewal writ in blood. Nature 423: 231-3
6. Dimmeler S, Zeiher AM (2004) Wanted! The best cell for cardiac regeneration. J Am Coll Cardiol 44: 464-6
7. Fuchs S, Baffour R, Zhou YF et al (2001) Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 37(6): 1726-32
8. Galinanes M, Loubani M, Davies J et al (2004) Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans. Cell Transplant 13: 7-13
9. Gerecht-Nir S, Itskovitz-Eldor J (2004) Human embryonic stem cells: a potential source for cellular therapy. Am J Transplant 4(Suppl 6): 51-7
10. Gill M, Dias S, Hattori K et al (2001) Vascular trauma induces rapid but transient mobilization of VEGFR2+AC133+ endothelial precursor cells. Circ Res 88: 167-74
11. Gulati R, Jevremovic D, Peterson TE et al (2003) Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 93: 1023-5
12. Hill JM, Zalos G, Halcox JPJ et al (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600
13. Kang HJ, Kim HS, Zhang SY et al (2004) Effects of intracoronary infusion of peripheral blood stem-cells mobilized with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomized clinical trial. Lancet 363: 751-6
14. Kawamoto A, Tkebuchava T, Yamaguchi J-I et al (2003) Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischaemia. Circulation 107: 461-8
15. Kocher AA, Schuster MD, Szabolcs MJ et al (2001) . Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: 430-6
16. Mathur A, Martin JF (2004) Stem cells and repair of the heart. Lancet 364: 183-92
17. Menasche P, Hagege AA, Vilquin J-T et al (2000) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41: 1078-83
18. Menasche P, Hagege AA, Scorsin M et al (2001) Myoblast transplantation for heart failure. Lancet 357: 279-80
19. Murry CE, Soonpaa MH, Reinecke H et al (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428: 664-8
20. Oh H, Bradfute SB, Gallardo TD et al (2003) Cardiac progenitor cells from adult myocardium: Homing, differentiation and fusion after infarction. Proc Nat Acad Sci (USA) 100: 12313-18
21. Orlic D, Kajstura J, Chimenti S et al (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-5
22. Perin EC, Dohmann HFR, Borojevic R et al (2003) Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107: 2294-302
23. Powell TM, Paul JD, Hill JM et al (2005) Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler. Thromb Vasc Biol 25(2): 296-301
24. Rehman J, Li J, Orschell CM et al (2003) Peripheral blood 'endothelial progenitor cells' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164-9
25. Rehman J, Li J, Parvathaneni L et al (2004) Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J Am Coll Cardiol 43(12): 2314-8
26. Shintani S, Murohara T, Ikeda H et al (2001) Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103: 2776-9
27. Smits PC, van Geuns R-JM, Poldermans D et al (2003) Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischaemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 42: 2063-9
28. Spyridopoulos I, Haendeler J, Urbich C et al (2004) Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor (TRF2) in endothelial progenitor cells. Circulation 110: 3136-42
29. Stamm C, Westphal B, Kleine H-D et al (2003) Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361: 45-6
30. Strauer BE, Brehm M, Zeus T et al (2001) Myocardial regeneration after intracoronary transplantation of human autologous stem cells following acute myocardial infarction. Dtsch med Wochenschr 126: 923-8
31. Strauer BE, Brehm M, Zeus T et al (2002) Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106: 1913-18
32. Terada N, Hamazaki T, Oka M et al (2002) Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416: 542-5
33. Tomita S, Li R-K, Weisel RD et al (1999) Autologous transplantation of bone marrow cells improved damaged heart function. Circulation 100: 247II-256II
34. Urbich C, Dimmeler S (2004) Endothelial progenitor cells: characterization and role in vascular biology. Circulation Research 95: 343-53
35. Urbich C, Heeschen C, Aicher A et al (2004) Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 110: 3136-42
36. Vasa M, Fichtlsherer S, Aiser A et al (2001a) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89(1): E1-7
37. Vasa M, Fichtischerer S, Adler et al (2001b) Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103(24): 2885-90
38. Wollert KC, Meyer GP, Lotz J et al (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomized controlled clinical trial. Lancet 364: 141-8
39. World Health Organization (2003) World Health Report. WHO, Geneva. www.who.int/whr/en